Roel Verhaak
@roelverhaak
Yale Neurosurgery prof studying brain tumors, husband, dad, football enthusiast, likes karaoke and drums. Disclosures: https://t.co/LZmv16girK
ID:531855475
https://www.verhaaklab.com/ 21-03-2012 02:35:31
5,5K Tweets
5,2K Followers
487 Following
📢 Announcing five new global #CancerGrandChallenges teams! 📢
We're thrilled to announce five new teams, each receiving up to $25m over five years to tackle some of cancer's toughest challenges.
Meet the teams: bit.ly/3Oqe58O
Cancer Research UK National Cancer Institute
We are thrilled to have published our recent findings regarding the way that GBM tumours adapt to, and survive, treatment in Genome Biology. This brief thread highlights what we found: 1/8
.Roel Verhaak Yale Department of Neurosurgery shares new research on the impact of treatment on the #glioma #cancer genome at #GrandRounds . Watch his talk now youtube.com/watch?v=nGqXvV…. Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp
Thrilled to finally share my 5+ years of postdoctoral work, published today in Cell!
“Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective”
Cell Joe Costello UCSF Neurosurgery UC San Francisco
authors.elsevier.com/c/1iS4bL7PXmefE
#OnlineFirst : Passenger Gene Co-Amplifications Create Collateral Therapeutic Vulnerabilities in Cancer, by Yi Bei, Anton Henssen, Jan Dörr et al.
bit.ly/48zC4ur
VomLaborInDiePraxis Charité - Universitätsmedizin Berlin Max Delbrück Center Berlin Institute of Health
The 2022 GLASS Data Resource can now be analyzed via cBioPortal: cbioportal.org/study/summary?…. Check out the new functions to analyze longitudinal profiles!
Just out: the T2-FLAIR mismatch sign is associated with favorable prognosis upon recurrence of IDH-mut astrocytoma. The result of a truly multidisciplinary, bench-to-bedside collaboration, we've learned so much from each other 🙏🏻 Karin van Garderen Roel Verhaak
academic.oup.com/noa/article-ab…
Newest GLASS paper online! The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen aacrjournals.org/cancerres/arti… congrats to Houtan Noushmehr